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ABSTRACT  Exposure of BALB/c-3T3 cells (clone A31) to platelet-derived  growth factor (PDGF) 
results in a rapid time- and dose-dependent alteration in the distribution of vinculin and actin. 
PDGF treatment (6-50 ng/ml) causes vinculin to disappear from adhesion plaques (within 2.5 
min after PDGF exposure) and  is followed  by an accumulation  of vinculin  in  punctate spots 
in the  perinuclear  region of the cell.  This alteration  in vinculin  distribution  is followed  by a 
disruption of actin-containing stress fibers (within 5 to 10 min after PDGF exposure). Vinculin 
reappears  in  adhesion  plaques  by 60  min after  PDGF addition  while  stress fiber  staining  is 
nondetectable at this time.  PDGF treatment had  no effect on talin, vimentin,  or microtubule 
distribution  in  BALB/c-3T3  cells;  in  addition,  exposure  of cells  to  5%  platelet-poor  plasma 
(PPP), 0.1% PPP, 30 ng/ml epidermal growth factor (EGF), 30 ng/ml somatomedin C, or 10 ~tM 
insulin also had no effect on vinculin or actin distribution. Other competence-inducing factors 
(fibroblast  growth  factor,  calcium  phosphate,  and  choleragen)  and  tumor  growth  factor 
produced similar alterations in vinculin and actin distribution as did PDGF, though not to the 
same extent.  PDGF treatment of cells for 60 min followed by exposure to EGF (0.1-30 ng/ml 
for as long as 8 h after PDGF removal), or 5% PPP resulted in the nontransient disappearance 
of vinculin staining within 10 min after EGF or PPP additions; PDGF followed by 0.1% PPP or 
10/zM insulin  had  no effect.  Treatment of cells with low doses of PDGF (3.25  ng/ml), which 
did not affect vinculin  or actin organization  in cells,  followed  by EGF (10 ng/ml),  resulted  in 
the disappearance of vinculin staining in adhesion plaques,  thus demonstrating the synergistic 
nature of PDGF and EGF. These data suggest that PDGF-induced competence and stimulation 
of cell  growth  in  quiescent  fibroblasts  are  associated  with  specific  rapid  alterations  in  the 
cellular organization of vinculin and actin. 
Platelet-derived growth factor (PDGF) ~  is the major mitogenic 
growth factor in  serum for cells of mesenchymal origin (2, 
44),  in addition to being a major chemoattractant for human 
neutrophils  and  monocytes  (13),  fibroblasts  (45,  49),  and 
smooth muscle cell~ (50),  thereby potentially playing an im- 
portant role in wound healing, atherogenesis, and cell growth. 
The biochemical mechanisms by which PDGF regulates the 
growth of cells is not known.  Recent work has shown that 
PDGF and growth factors in platelet-poor plasma (PPP) func- 
Abbreviations used in this paper."  C.T. Cholera toxin; DME, Dul- 
becco's modified Eagle's medium;  EGF, epidermal growth factor; 
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tion in a synergistic manner to control the growth of BALB/ 
c-3T3 fibroblasts in tissue culture (42).  PDGF alone cannot 
initiate growth of  quiescent cells; however, transient treatment 
of cells  with  PDGF  followed  by  plasma  results  in  DNA 
synthesis and cell growth (41). Further work revealed that the 
plasma requirement for the stimulation of DNA synthesis in 
BALB/c-3T3 cells can be replaced by epidermal growth factor 
(EGF) and either insulin or Somatomedin C (SmC) (36). An 
interesting finding of  these studies was that only brief  exposure 
to PDGF was required to prime cells for responsiveness to 
plasma, and that this sensitized state (competence) lasted long 
after removal of PDGF from cells (57). This PDGF-induced 
competent state was found to decay with a half life of 18 h, 
and could also be induced by treatment of cells with fibroblast 
1031 growth factor (FGF), macrophage-derived growth factor, or 
calcium phosphate (53,  57).  Lastly, choleragen treatment of 
cells was found to potentiate the action of PDGF in compe- 
tence induction as well as abrogate the requirement for EGF 
in cell  cycle progression (32).  To date, no cellular respond, 
other than  induction  of DNA  synthesis,  has been demon- 
strated  in  cells following exposure to  EGF which  required 
prior exposure of cells to PDGF. 
The finding that only brief exposure to PDGF is required 
to induce competence suggests that rapid biochemical events 
which follow PDGF binding are important in the induction 
of competence.  Shortly  after binding  of growth  factors,  a 
plethora  of metabolic changes  in  cells  has been  shown  to 
occur. These rapid changes include alterations in the activity 
of plasma membrane Na+/H  * antiport systems (31),  altera- 
tions in ion fluxes (5),  mobilization of intracellular calcium 
(34), alkalinization of intracellular pH (4), and phosphoryla- 
tion  of plasma  membrane  phospholipids  (18)  and  growth 
factor receptors (8). The latter two observations have caused 
an intense amount of interest based on the findings that tumor 
promotors have been shown to phosphorylate specific plasma 
membrane phospholipids (22), and that growth factor recep- 
tors for PDGF and EGF share with some oncogene proteins 
a  tyrosine protein  kinase  activity (8).  Exposure  of cells  to 
PDGF has been  found to  result  in  the  phosphorylation of 
42-,  43-, and 45-kD proteins which seem to be localized at 
the  plasma  membrane  (10).  To  date,  the  identity  of the 
proteins which are phosphorylated upon PDGF addition have 
yet to be identified. 
In addition to the rapid events which occur at the plasma 
membrane  of cells  following  PDGF  addition,  subsequent 
effects on  gene expression  have been  documented  (30).  A 
number of specific proteins have been identified in BALB/c- 
3T3  cells  induced  by  PDGF  addition  (40);  one  of these 
proteins which  occurs early after PDGF exposure, a  29-kD 
protein, has been localized to the nucleus (38), but its function 
is  unknown.  Furthermore,  PDGF  rapidly  stimulates  the 
expression ofmyc andros in quiescent BALB/c-3T3 cells (30). 
If tyrosine phosphorylation of growth  factor receptors and 
cellular substrates is important for growth factor action, and 
for growth factor activity that can be modulated at the tran- 
scriptional level in the nucleus, it is important to identify the 
intracellular proteins that may mediate the passage of infor- 
mation  from  the  plasma  membrane  to  the  nucleus.  The 
findings that certain  growth  factor receptors and  oncogene 
protein products possess tyrosine kinase activity (23,  26),  in 
conjunction with the localization of oncogene products to the 
plasma  membrane (and  in  one  specific case,  to  adhesion 
plaques [43]), prompted us to examine whether PDGF addi- 
tion to cells would affect adhesion plaque structure.  PDGF 
addition to BALB/c-3T3 cells results in a rapid and reversible 
alteration in the distribution of vinculin and actin that is very 
reminiscent of that observed in virally transformed cells (26, 
48,  50),  which  is  thought to be mediated through  tyrosine 
phosphorylation. We demonstrate that this alteration is spe- 
cific for PDGF and other competence-inducing factors and 
not  for other growth  factors required  for progression  (e.g., 
EGF and SmC), and that PDGF and EGF can exert a syner- 
gistic effect with respect to the distribution of vinculin from 
adhesion plaques, which can be related to mitogenesis in these 
cells. We also report that the loss of vinculin from adhesion 
plaque in  response to EGF first requires pretreatment with 
PDGF.  This  finding  constitutes  the  first  description  of a 
specific cellular response to EGF treatment which occurs only 
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specific cellular response to EGF treatment which occurs only 
in PDGF-induced competent BALB/c-3T3 cells, but not in 
quiescent cells. Previous portions of this work have appeared 
in abstract form (25). 
MATERIALS  AND  METHODS 
Cell Culture:  BALB/c-3T3  cells (clone A31) were grown in Dulbecco's 
modified  Eagle's  medium  (DME)/10%  heat-inactivated calf serum/4  mM 
glutamine, supplemented with penicillin at 50 U/ml and streptomycin at 50 
#g/ml in humidified 5% CO2/95% air at 37"C. Cells were seeded at 4-5 x  l05 
cells/l.76 cm  2 well on glass coverslips, and cultures were used for experiments 
4-5 d after plating. 
Preparation of Growth Factors:  Highly purified PDGF was pre- 
pared from  boiled extracts of outdated human platelets by a combination of 
reported procedures  (24, 41, 42). The PDGF was greater than 25% pure and 
was highly mitogenic  at 2- l0 ng/ml in microtiter  assays with density-dependent 
inhibited BALB/c-3T3  cells as described  by Pledger  et al.  (40). The  PDGF 
preparation did not contain measurable tumor growth factor (TGF) activity  as 
demonstrated by radio receptor assay. PPP was purified as previously  described 
from  peripheral  venous blood drawn from  healthy volunteers (41).  EGF was 
pUrified from  mouse submaxillary glands by  the  procedure  of Savage and 
Cohen  (46).  FGF  was  a  gift  of Dr.  Dennis Gospodarowicz (University of 
California at San Francisco), while platelet-derived  ~3-TGF was a gift from  Dr. 
Hal Moses (Mayo Clinic, Rochester,  MN).  Bovine  insulin and cholera toxin 
(C.T.) were purchased from  Sigma Chemical Co., St. Louis, MO. SmC was a 
gift from Dr. Judson Van Wyk. 
[3H]Thymidine (DNA Synthesis) Assay:  BALB/c-3T3  cells were 
grown in  Falcon 24-well  tissue culture plates for 4-5 d containing 2.0 ml of 
serum-supplemented DME.  Confluent quiescent cultures were transferred  to 
fresh medium containing PDGF,  PPP,  and [3H]thymidine.  After  incubation 
for 36 h, the cultures were processed for autoradiography  as previously  described 
(41, 42). 
Immunofluorescence:  After exposure of BALB/c-3T3 cells to vary- 
ing concentration of growth factors,  serum, or hormones in 0.5 ml of medium 
for appropriate times, cells were processed  for the demonstration of vinculin, 
talin, or actin as follows. 
Cells were fixed in 3.7% formaldehyde in phosphate-buffered  saline (PBS) 
(pH  7.4),  1 mM magnesium chloride (MgCl2), and 0.1  mM calcium chloride 
(CaCl2), for  5 rain at room temperature, The coverslips  containing the cells 
were rinsed three times in PBS and extracted for 3 rain at room temperature 
in 0.1%  Triton  X-100  containing 1 mM  MgCl2 and 0.1  mM  CaCI2. After 
rinsing in PBS, the coverslips were incubated in either a  1:25 dilution of rabbit 
anti-vinculin antibody, a  1:25 dilution of rabbit  anti-talin antibody,  or  a 
combination (final dilution of 1:25) of rabbit anti-talin and guinea pig anti- 
vinculin.  The antibodies  directed against  vinculin  and talin were kindly  supplied 
to us by Keith Burridge (University  of North Carolina at Chapel Hill) and have 
been previously characterized with regard to their specificity (19). Coverslips 
were incubated for 30 min at 37°C, rinsed three times in PBS and incubated in 
the following second  antibodies. The coverslips were incubated in fluorescein 
goat anti-rabbit lgG or fluorescein goat anti-guinea pig IgG (Flow Laboratories~ 
McLean,  VA). The second  antibodies also contained Rhodamine-Phalloidin 
(which binds to F-actin), obtained from Molecular Probes (Junction City, OR), 
at a concentration of 5 ul of Rhodamine-Phalloidin/100  ul second  antibody: 
this allowed us to visualize  the distribution ofvinculin or talin and actin in the 
same cell.  When cells were  stained with a  mixture of rabbit anti-talin and 
guinea pig anti-vinculin,  the second antibody incubation was performed using 
a mixture of fluorescein goat anti-rabbit IgG and Rhodamine-sheep anti guinea 
pig IgG which did not contain any Rhodamine-Phalloidin.  The coverslips were 
incubated in second antibody for 30 min at 37°C, rinsed three times in PBS, 
and mounted onto slides in a  mixture of 60% glycerol/40% PBS containing 
5% n-propyl gallate. Tubulin and vimentin were visualized  after the fixation of 
cells in -20°C methanol for l0 rain with a  1:50 dilution of rabbit antitubulin 
antibody which had been raised against sea urchin vinblastine crystals (kindly 
supplied by Keigi Fujiwara at the Harvard Medical School) and a  1:5 dilution 
of mouse monoclonal antivimentin antibody purchased from  LAB systems of 
Chicago,  IL.  Incubation conditions were as previously described  except  that 
cells were  incubated in  a  1:20 dilution of fluorescein  goat anti-rabbit lgG 
(tuhulin) and Rhodamine guinea pig anti-mouse IgG (vimentin). This fixation 
procedure did not allow the visualization  of actin with Rhodamine-Phalloidin. 
After mounting onto slides, photographs of the cells were taken on a Zeiss IM- 
35 inverted microscope using epi-illumination  and filter  sets which discriminate 
between fluorescein and Rhodamine fluorescence.  Photographs  were taken on 
Tri-X  film and developed  at an effective ASA of 1600. For each experiment, 
150-200  cells per treatment were  counted  and  scored  for  the  presence  or 
absence  of vineulin and  actin staining, which were  distributed in adhesion 
plaques (focal contacts) and stress fibers, respectively. RESULTS 
PDGF Effects on the Cytoskeleton 
Exposure of quiescent BALB/c-3T3 cells to PDOF results 
in a  rapid time- and dose-dependent alteration in the distri- 
bution  of vinculin  and  actin.  In  untreated  cells,  vinculin 
staining is concentrated in adhesion plaques near the cell edge 
or  at  areas  of cell-cell  contact  (Fig.  1A), as  well  as  being 
diffusely distributed  throughout  the  cytoplasm. The  higher 
intensity observed in the perinuelear region may be due to a 
higher concentration of vinculin or a larger accessible volume 
in  this region  of the  cell.  Actin  is  found disposed in  stress 
fibers  (Fig.  1D)  which  course  throughout  the  cell  or  are 
concentrated  around  the  cell  periphery.  These  stress fibers 
can often be seen terminating in vinculin-containing adhesion 
plaques. Within 2.5  min after addition of 50 ng/ml PDGF to 
BALB/c-3T3  cells,  vinculin  staining  is  lost  from adhesion 
plaques (Fig.  1  B), and assumes a more punctate distribution 
in  the  cytoplasm, primarily concentrated at the cell  center. 
Actin organization is unaffected at this time (Fig.  l E). By 60 
rain  of exposure to  PDGF,  the  vinculin  staining  has reap- 
peared  in  adhesion  plaques  (Fig.  I C),  while  there  is  little 
staining  of actin  in  cells  at this time (Fig.  1F).  This latter 
finding is in agreement with the data of Bochus and Stiles (3) 
and  Mellstrrm  et  al.  (33),  who  have  reported  that  PDGF 
addition  to BALB/c-3T3 cells  resulted  in  the  rapid and  re- 
versible loss of microfilaments and that treatment of human 
diploid glial cells with PDGF resulted in early reorganization 
of actin microfilaments and membrane ruffling. 
To determine whether exposure of cells  to PDGF specifi- 
cally caused disruption  of vinculin and actin or also caused 
alterations in other cytoskeletal structures as well, we exposed 
cells  to PDGF (12  ng/ml for 20  min at 37°C),  fixed them, 
and processed them for the immunofluorescent detection of 
talin  (adhesion  plaque  protein  [6]),  vimentin (intermediate 
filaments), or tubulin (microtubules). As can be seen in Fig. 
2,  although  PDGF  treatment  caused  the  disappearance  of 
vinculin staining in cells (Fig.  2, A and B), talin distribution 
was unaffected (cf. Fig. 2, C and D). While the images in this 
figure were obtained using rabbit anti-talin antibody, identical 
experiments  using  guinea  pig anti-vinculin  antibodies  and 
rabbit anti-talin  antibodies demonstrated disruption  of vin- 
culin staining with the preservation of talin adhesion plaque 
staining. These results suggest that PDGF exposure results in 
a  specific disruption  or removal of vinculin  from adhesion 
plaques while still maintaining the adhesion plaque structure 
intact (as evidenced by the lack of effect of PDGF treatment 
on talin).  Whether the reappearance of vinculin in adhesion 
plaques by 60 min after PDGF exposure results from vinculin 
accumulation to previously existing adhesion plaques is not 
FIGURE  1  Effect of PDGF treatment on vinculin (A-C) and actin (D-F) distribution in BALB/c-3T3 cells. In untreated cells, vinculin 
staining is found predominantly in adhesion plaques (arrowheads in A) near sites  of cell-cell contact or cell-substrate interaction 
and in a diffuse distribution throughout the cytoplasm. Actin is disposed as stress fibers which course throughout the cell or are 
concentrated around the cell periphery (D).  Within 2.5-5 min after exposure of cells to 50 ng/ml of PDGF, vinculin staining has 
disappeared from adhesion plaques and assumes a punctate perinuclear distribution (B). The distribution of actin is unchanged 
at this time (E). By 60  min after continual exposure of cells to 50 ng/ml of PDGF, vinculin  has  reappeared in adhesion plaques 
(arrowheads in C), while stress fiber staining is essentially absent (F). n, Nucleus. Bars, 10 #M. 
HerMAN AND  PLEDGer  PDCF Effects on Vinculin  and Actin  1033 FIGURE  2  Effect of PDGF treatment (12  ng/ml for 20 min at 37°C) on vinculin (A and B), talin (C and D), vimentin (E and F), and 
microtubule (G and H) distribution in BALB/c~3T3  cells. Vinculin  is concentrated in adhesion plaques at sites  of cell-cell or cell- 
substratum contact  in  untreated cells (arrowheads in A). After exposure to  PDGF,  vinculin  staining in adhesion plaques is lost 
(arrowheads in B) and assumes a punctate distribution within the cytoplasm. Talin, another adhesion plaque protein (C), has an 
identical distribution to that of vinculin, being localized in adhesion plaques. Unlike vinculin,  PDGF treatment has  no effect on 
talin  distribution  or staining (D;  cell  edge delineated  by  arrowhead).  Intermediate filaments (vimentin)  display an  interlacing 
network of fibers (E) which are also unaffected by PDGF treatment (F). Microtubules are disposed as a radial network of fibers 
originating from a  perinuclear organizing center (arrowhead in G) and this distribution is unaltered by  PDGF  treatment (H).  n, 
Nucleus. Bars, 10 #M. 
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intermediate filaments (vimentin [Fig. 2, E and F]) or micro- 
tubules (tubulin [Fig. 2, G and/at]). No change in cell shape 
was noted during these experiments, suggesting that the cells 
remained attached to the substrate for the duration of PDGF 
exposure. Exposure of BALB/c-3T3 cells to EGF (10 ng/ml), 
insulin (10 ~M), SmC (30 ng/ml), 5% PPP, or 0. 1% PPP had 
no effect on  vinculin or actin distribution in  BALB/c-3T3 
cells. 
Fig. 3 illustrates the time- and dose-dependent disappear- 
ance of vinculin staining from adhesion plaque structures or 
actin stress  fiber staining in  cells after exposure of cells to 
varying doses  of PDGF.  At  very high  doses  (50  ng/ml), 
adhesion plaque staining disappears (up to 95%) within 2.5 
min after PDGF addition (Fig. 3A), while stress fiber staining 
does not disappear until 5-10 min after exposure to PDGF 
(Fig. 3B). Progressively lower doses of PDGF (25 or 12 ng/ 
ml) bring about a somewhat slower but quantitatively similar 
disappearance in vinculin staining; however, the kinetics of 
the disruption of actin stress  fibers appears independent of 
dose at  these concentrations. Cells  exposed to  6.25  ng/ml 
PDGF display only a partial disappearance of vinculin stain- 
ing from adhesion plaques (~50% at 15 rain after treatment), 
whereas no effect was found on stress fibers at this concentra- 
tion. This figure also illustrates that between 30 and 60 rain 
after exposure of cells to PDGF, vinculin staining reappears 
in adhesion plaques (Fig.  3.4),  while stress  fibers have not 
recovered even by 90  min after PDGF addition (Fig.  3B). 
The findings that PDGF treatment results in the rapid disap- 
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pearance of vinculin from the adhesion plaques before the 
disappearance of actin-containing stress  fibers suggests that 
the primary effect of PDGF treatment is to cause vinculin 
disruption from adhesion plaques. The subsequent disruption 
of actin-containing  stress  fibers  may be  secondary to  the 
disruption of vinculin in the adhesion plaques since many 
morphological and biochemical studies have indicated that 
actin-containing stress fibers are tethered at adhesion plaques 
or focal contacts through an interaction with vinculin (21). 
Specificity  of Growth  Factor Modulation  of 
Vinculin  Distribution 
When BALB/c-3T3 cells are rendered competent by brief 
exposure to  PDGF,  the  subsequent  addition  of EGF and 
insulin-like  growth  factors  (or  PPP)  induces  progression 
through the G0/GI phases of the cell cycle and entry into S 
phase.  In addition to PDGF, other agents,  including FGF, 
calcium  phosphate  (Ca3[PO4]),  and  a  macrophage-derived 
growth  factor have been  shown  to  be able  to  induce this 
competent state in BALB/c-3T3 cells. Table I illustrates the 
effect some of these compounds and  various other growth 
factors or hormones on the distribution of vinculin and actin 
staining  shortly after addition  to density-arrested BALB/c- 
3T3 cells.  Both FGF and CaCb disrupted adhesion plaque 
and stress  fiber staining, though to a lesser extent than did 
PDGF (Table I). TGF at higher concentrations ( l- 10 ng/ml) 
also caused a disappearance of vinculin and actin staining in 
cells. At the concentrations of PDGF used in our studies, the 
FIGURE 3  Time- and dose-dependent effect 
of  PDGF treatment  on  vinculin  adhesion 
plaque  and  actin  stress fiber  staining  in 
BALB/c-3T3 cells exposed to PDGF. At high 
PDGF concentrations,  vinculin  staining  dis- 
appears within 2.5  min after PDGF addition 
(top), while actin-containing stress fibers  do 
not undergo disruption until 10 min after ex- 
posure  of cells to  PDGF (bottom). Whereas 
the disappearance  of vinculin staining is de- 
pendent on  the dose of PDGF (top), stress 
fiber break-down appears relatively dose-in- 
dependent (at the  higher PDGF concentra- 
tions) (bottom). By 60 min after PDGF addi- 
tion, vinculin staining has reappeared in adhe- 
sion  plaques  (top), while most  cells are still 
devoid of actin-containing stress fibers (bot- 
tom). 
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radio  receptor  assay  (personal  communication,  Dr.  Hal 
Moses), and therefore could not be responsible for PDGF's 
effect on vinculin and actin distribution. Choleragen (cholera 
toxin [C.T.]), which has been shown to enhance DNA syn- 
thesis by potentiating the action of PDGF (32), caused a very 
efficient and rapid disruption of vinculin staining in adhesion 
plaques  and  stress  fiber  staining  in  BALB/c-3T3  cells.  In 
contrast to PDGF or other BALB/c-3T3 competence factors, 
exposure of cells to EGF (0.1-30 ng/ml), PPP (5% or 0.1%), 
SmC (30 ng/ml), or insulin (10 ~M) had no effect on vinculin 
adhesion plaque or actin stress fiber staining in the BALB/c- 
3T3  cells.  None of the  agents listed in  Table I altered the 
staining patterns of any other cytoskeletal structures during 
these brief incubation periods. 
Effect of Addition of EGF, PPP, or Insulin on 
Vinculin and Actin Distribution after Brief 
Exposure  to PDGF 
Previous  work  has  shown  that  subsequent to  transient 
exposure to  PDGF,  ceils could  be induced  to  enter  the  S 
TABLE  I 
Percent Disruption  of Vinculin and Actin Staining at  15 Min 
after Ligand Addition 
Ligand  Dose 
% cells  % cells 
without vin-  without 
culin stain-  stress 
ing in adhe-  fiber 
sion plaques  staining 
None {control)  --  <3  <5 
PDGF  6.5 ng]ml  18  7 
12 ng/ml  83  93 
25 ng/ml  93  88 
TGF  0.1  ng/ml  65  50 
1 ng/ml  67  54 
I0 ng/ml  30  50 
FGF  25 ng/ml  15  12 
50 ng/ml  27  23 
100 ng/ml  29  30 
C.T.  1 ng/ml  68  88 
100 ng/ml  90  92 
1,000 ng/ml  88  90 
CaCI2  15 mM  35  50 
EGF  0.1  ng/ml  <5  <5 
I  ng/ml  <5  <5 
30 ng/ml  <5  <5 
PPP  5%  <5  <5 
0.1%  <5  <5 
SmC  30 ng/ml  <5  <5 
Insulin  10 ~,M  <5  <5 
5-d cultures of BALB/c-3T3 cells grown on coverslips and maintained in DME 
containing  10% calf serum were treated  with DME containing  PDGF, TGF, 
FGI-, EGF, C.T., CaCI2, PPP, SmC, or insulin at the concentrations  indicated 
for  15 min  at  37°C,  and fixed and  processed for the immunofluorescent 
demonstration  of vinculin  and actin as described in the Materials and Meth- 
ods. 150  200 cells per coverslip were counted and scored for the presence 
or absence of adhesion  plaque  or stress fiber staining. The  percentage of 
cells without staining for adhesion plaques or stress fibers is indicated. 
1036  THE JOURNAL OF  CELL BIOLOGY - VOLUME 100,  1985 
phase of the cell cycle by plasma (39). Further investigations 
have demonstrated that the requirement for plasma could be 
replaced by EGF, and either insulin or SmC (35). In addition, 
it  was  found  that  the  competent  state  induced  by  PDGF 
decayed with a half life of 18 h; addition of plasma for up to 
13-18 h after removal of PDGF still resulted in the entry of 
cells into S phase (50).  We investigated whether addition of 
EGF,  insulin,  or  PPP  after removal of PDGF  led  to  any 
rearrangement in vinculin or actin distributions in BALB/c- 
3T3 cells. The results of this study are presented in Fig. 4. As 
demonstrated  earlier,  vinculin  staining  within  adhesion 
plaques reappears within 60 min after PDGF exposure, while 
actin stress fibers have not reformed by this time (Fig.  1,  b 
and c, and Fig. 4 a). When PDGF was removed from the cells 
at this  time and  EGF was added,  vinculin  staining within 
adhesion plaques disappeared within  15 min (Fig.  4 b). This 
response was found to occur up to 8 h after removal of PDGF 
(Fig. 4 c), and could also be brought about by the addition of 
5% PPP after the removal of PDGF. These treatments had 
no effect on  talin  staining  or the  distribution  (staining)  of 
other cytoskeletal structures. Addition of 10 ~M insulin (Fig. 
4f) or 0.1% PPP (Fig. 4e) after the removal of PDGF had no 
effect on the distribution of vinculin staining in these cells. 
These  results  suggest  that  the  alterations  observed  in  the 
vinculin  component  of adhesion  plaques,  and  stress  fiber 
structure,  are  related  to  the  induction  of competence  by 
PDGF and the further signaling of cells to enter the S phase 
by PPP or EGF. 
To further test the hypothesis that vinculin disappearance 
from adhesion  plaques  is  correlated  with  the  initiation  of 
growth of quiescent cells by PDGF, we measured the amount 
of DNA  synthesis ([3H]thymidine uptake) as a  function  of 
PDGF concentration (after further treatment of cells with 5 % 
PPP).  The percentage of cells which took up [gH]thymidine 
was correlated with the percentage of cells lacking adhesion 
plaque vinculin staining as a function of PDGF concentration. 
These data are plotted and shown in Fig.  5. As can be seen, 
the actual percentage of cells without adhesion plaque vin- 
culin staining is almost identical to the percentage of the cells 
which were labeled with [3H]thymidine. The close correlation 
between the disappearance of vinculin from adhesion plaques 
and cell growth (see inset,  Fig. 5) suggests that an early event 
in the initiation of cell growth by PDGF in quiescent BALB/ 
c-3T3 cells may involve the reversible disruption of vinculin 
from adhesion plaques or focal contacts. 
Synergy between PDGF and EGF or PPP 
PDGF has been shown to sensitize BALB/c-3T3 cells  to 
EGF  and  reduce  the  concentration  of  EGF  required  for 
mitogenic stimulation of 10Tt/2 cells (39). This effect of PDGF 
may occur through  reactions that affect the  EGF receptor, 
since PDGF treatment alters EGF receptor number (56). We 
wondered if this synergy between PDGF and EGF (the  in- 
creased sensitivity of cells to EGF after exposure to PDGF) 
was also reflected in changes in the distribution  of vinculin 
and actin staining in cells.  We approached this question by 
first treating cells with a high (12  ng/ml) or low dose (3.25 
ng/ml) of PDGF for 60 min followed by treatment with EGF 
( 10 ng/ml), insulin (10 uM), or PPP (5% or 0.1%). The results 
of these experiments are shown in Table II. Treatment of cells 
with low doses of PDGF (3.25  ng/ml) did not result in loss of 
vinculin staining from adhesion plaques; exposure of cells to 
high doses of PDGF (12 ng/ml) results in the transient dis- 
appearance of vinculin staining in adhesion plaques (see Fig. FIGURE 4  Vinculin staining in cells treated with 12 ng/ml PDGF for 60 rain (A) followed by 10 ng/ml EGF (B and C), 5% PPP (D), 
0.1% PPP (E), or 10 #M insulin for 15 rain at 37°C. Vinculin staining reappears in adhesion plaques within 60 rain after exposure 
to PDGF (A); subsequent removal of PDGF followed by addition of 10 ng/ml EGF results in the disappearance of vinculin staining 
within 15 min (B). Addition of EGF up to 8 h after removal of PDGF continues to result in the abolishment of vinculin staining in 
adhesion plaques within 15 rain of EGF addition (C). PDGF treatment followed by addition of 5% PPP also abolished vinculin 
adhesion plaque staining (D), while 0.1% PPP (E) or 10/~M insulin (F) following PDGF treatment had no effect on vinculin staining 
(compare arrowheads in A and F). n, Nucleus. Bars, 10/~M. 
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FIGURE 5  DNA synthesis (0) and disappearance of vinculin stain- 
ing from adhesion plaques (O) as a function of PDGF concentration. 
The percentage  of cells which contain labeled nuclei closely par- 
allels  the  percentage  of cells  without  vinculin adhesion plaque 
staining at all doses of PDGF (see  inset). 
1), which had returned by 60 min after PDGF addition (Table 
II). Addition of EGF to cells after a 60-rain exposure to low 
doses of PDGF results in the rapid disappearance of vinculin 
adhesion plaque staining and actin stress fiber staining. Sim- 
ilar treatment with  5%  PPP yielded the same results,  while 
treatment of cells with EGF alone or with 0.1%  PPP or  10 
uM insulin following PDGF had no effect.  Thus, PDGF and 
EGF  seem  to  act  in  a  synergistic  manner with  respect  to 
alterations in the cellular distribution of vinculin and actin. 
DISCUSSION 
The biochemical mechanisms which regulate cell growth are 
unknown.  The use of serum-derived growth factors in con- 
junction with tissue culture cells has allowed investigators to 
study  biochemical  changes  associated  with  growth.  These 
approaches have led to the discovery that different phases of 
the  cell  cycle can  be  regulated  by different  serum-derived 
growth  factors  (35,  36,  39).  Specifically,  PDGF  stimulates 
arrested  (quiescent)  BALB/c-3T3  cells,  in  a  concentration- 
and  temperature-dependent manner,  to  leave Go and  enter 
the cell  cycle (41).  The traverse of Go/G,  and  entry into  S 
phase  can  be  facilitated  by  EGF  and  SmC  (40,  42).  The 
induction  of competence  and  growth  initiation  by  PDGF 
apparently involves increases in gene expression as illustrated 
by the  induction  of unique  mRNA and  proteins (52).  The 
mechanism whereby PDGF alters gene expression by binding 
specific receptors is unknown and remains an important focus 
of investigation. 
The findings that only brief exposure of cells to PDGF is 
necessary to  render  cells  sensitive to  EGF  and  SmC  (5 l) 
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Vinculin and Actin Staining 75 Min after Sequential Additions 
of Ligands 
Primary ligand  Secondary ligand 
% cells 
without 
vinculin  % cells 
staining  without 
in adhe-  stress 
sion  fiber 
plaques  staining 
Dose  Dose 
PDGF (3.25 ng/ml)  --  11  10 
PDGF (12 ng/ml)  23  85 
EGF (10 ng]ml)  --  <5  <5 
PDGF (12 ng/ml)  EGF (10 ng/ml)  68  74 
PDGF (3.25 ng/ml)  EGF (10 ng/ml)  72  71 
PDGF (3.25  ng]ml)  5.0% PPP  68  35 
PDG F (3.25  ng]ml)  0.1% PPP  13  11 
PDGF (3.25 ng/ml)  Insulin (10 ttM)  21  18 
5-d old BALB/c-3T3 cells grown in DME were exposed to the same medium 
containing the primary ligand at the concentrations indicated in the table for 
60 min at 37°C. The medium containing the primary ligand was removed 
and replaced by DME containing the secondary ligand at the concentrations 
indicated for  15 rain at 37°C. Cells were then fixed and processed for the 
immunofluorescent demonstration of vinculin and actin as described in the 
Materials and Methods section. 150-200 cells were scored for the presence 
or absence of adhesion plaque or stress fiber  staining. The percentage of 
ce(Is without adhesion plaque or stress fiber staining is indicated. 
suggest that rapid alterations in cellular structure or function 
which  occur  early  after  PDGF  addition  to  cells  may  be 
responsible for PDGF-induced competence. We have found 
that exposure of BALB/c-3T3 cells to PDGF leads to rapid 
and reversible, time- and dose-dependent alterations in vin- 
culin  and  actin  distribution.  Within  2.5  rain  after  PDGF 
exposure, vinculin staining disappears from adhesion plaques 
(Fig.  l)  while  actin  staining,  in  the  form  of stress  fibers, 
becomes disrupted between 5 and  l0 min after PDGF addi- 
tion. Adhesion plaques (focal contacts) are regions where actin 
microfilaments terminate in cells such as cultured fibroblasts 
and where the plasma membrane comes close to the under- 
lying  substrate.  Various  actin-binding  proteins  have  been 
localized to this region of the plasma membrane (l,  7,  20, 
21), and include a-actinin, fimbrin, talin, and vinculin. Pre- 
vious findings using immunocytochemistry indicate that actin 
microfilaments terminate in vinculin contained in adhesion 
plaques  or  focal  contacts  (21).  The  PDGF-induced  disap- 
pearance of vinculin from adhesion plaques is reversible in 
that, by 60 min after treatment of cells with PDGF, vinculin 
staining has reappeared in adhesion plaques, whereas stress 
fibers have not reformed by this time. Stress fiber staining 
does eventually reappear within  120-180  min  after PDGF 
addition (3) (also Herman, B., and W. J. Hedger, unpublished 
data).  The  slower kinetics  of actin  stress  fiber disruption, 
coupled with the findings that stabilization of actin microfi- 
laments with phalloidin (3) does not prevent PDGF-induced 
competence, suggests  that  microfilament breakdown  is not 
required for induction of competence but is probably second- 
ary to the disruption of vinculin from adhesion plaques. The 
findings that no microfilament disruption occurs at concen- 
trations of PDGF which result in disappearance of -50% of 
the detectable vinculin staining (see Fig. 3), and that a syner- 
gistic  effect  of PDGF  and  EGF  with  respect  to  vinculin 
disappearance from adhesion plaques and cell growth can be 
demonstrated at these low doses of PDGF,  strengthens the 
argument that micro  filament breakdown is not important in 
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the induction of competence. 
That the effect of PDGF is specific for vinculin is shown 
by the  findings that neither talin (another adhesion plaque 
protein), vimentin (intermediate filament), nor tubulin (mi- 
crotubule) staining is affected by PDGF treatment (see Fig. 
2).  This  suggests  that  focal  contacts  or  adhesion  plaques 
remain  intact  in  cells  after  exposure  to  PDGF,  and  that 
vinculin  is specifically removed from these  structures after 
PDGF  addition.  These  results  are  in  agreement with  our 
observations that no change in cell shape occurs during the 
alterations in vinculin distribution after exposure of cells to 
PDGF. Previous work from other laboratories (33) has shown 
that PDGF treatment (1.3  nM) of serum-starved glial cells 
results in a large increase in membrane ruffling activity and 
extension of lamellapodia. These changes, which occur within 
1 to  60  min  of PDGF  addition,  are  also  associated  with 
translocation of membrane from the cell periphery to the cell 
center and  an  increased  shuttling  of intracellular  particles. 
These alterations in membrane activity were associated with 
a rearrangement of actin microfilaments yielding a substrate 
set of stress fibers as well as a  high concentration  of actin 
filaments in the membrane ruffles.  PDGF treatment did not 
cause the disappearance of actin staining in these cells as it 
does in  BALB/c-3T3 (see  Fig.  1);  it is not known whether 
similar changes in membrane ruffling activity occur shortly 
after PDGF treatment of BALB/c-3T3 cells and if so whether 
the  alterations we observe in  vinculin  distribution  may be 
related  to  this  phenomenon.  It is  interesting  to  note  that 
similar changes in  ruffling activity, increases in micropino- 
cytic activity, and microfilament organization have been re- 
ported in  A431  cells shortly after treatment with  EGF (9). 
Thus an early effect of growth factors in general may be to 
enhance membrane turnover activity and cause alterations in 
intraceUular  actin  distribution.  It is  not  known,  however, 
whether these alterations in membrane activities and micro- 
filament distributions are related to cell growth and whether 
concomitant disruption  of vinculin  from adhesion  plaques 
occurs during these processes. 
The hypothesis that alterations in vinculin may be related 
to competence induction in BALB/c-3T3 cells is strengthened 
by the findings that other agents which have been shown to 
induce competence in BALB/c-3T3 cells (FGF, choleragen, 
and  Ca2+), also  cause  the  disappearance  of vinculin  from 
adhesion plaques. Other growth factors (e.g.,  EGF or SmC) 
and insulin had no effect on vinculin staining in these cells, 
suggesting that the disruption of vinculin staining in adhesion 
plaques is not a general biological effect of growth factor or 
hormone binding. How PDGF might induce competence in 
BALB/c-3T3 cells is not known. The findings that (a) chol- 
eragen potentiates the effects of suboptimal PDGF concentra- 
tions (56), (b) IBMX enhances the action of choleragen (32), 
and (c) the differential sensitivity of various cell lines to PDGF 
can be related to their intracellular cAMP concentration (37), 
suggest  that PDGF can sensitize cells to the action of EGF 
possibly through a cAMP-mediated mechanism. It is interest- 
ing to note that PDGF has also been shown to decrease EGF 
binding to  BALB/c-3T3  cells  (56)  which  is augmented by 
cholera toxin treatment. Whether the decrease in the amount 
of EGF bound is due to EGF receptor internalization or due 
to masking of plasma membrane receptors is not known; this 
decrease suggests, however, that PDGF may make cells com- 
petent by causing down regulation of the EGF receptor which 
is  necessary  for  mitogenesis.  Alternatively,  the  action  of PDGF and EGF may be via two different pathways necessary 
for the entry of cells into S phase. 
Further support for a role of vinculin in the interaction of 
PDGF  and  EGF  in  cell  cycle progression  comes from our 
findings  that  vinculin  staining  disappears  from  adhesion 
plaques in cells treated with EGF after exposure to low doses 
of PDGF, which by itself does not disrupt vinculin adhesion 
plaque staining (see Table II). This strengthens the interpre- 
tation that PDGF  can  sensitize cells to the action of other 
specific  growth  factors;  the  observation  that  this  vinculin 
disruption from adhesion plaques can still occur even up to 
8 h after PDGF removal (Fig. 4) is consistent with the prop- 
erties of PDGF-induced competence. Lastly, the nearly equiv- 
alent percentage of cells which demonstrate absence of vin- 
culin  adhesion  plaque  staining  and  [3H]thymidine-labeled 
nuclei at various concentrations of PDGF suggests that vin- 
culin disruption is important for the induction of competence 
and entry of cells into the cell cycle. 
Binding of PDGF to purified plasma membranes results in 
the rapid  stimulation of a  membrane-associated protein ki- 
nase, which phosphorylates two major polypeptides (molec- 
ular  weights  of  185,000  and  130,000)  and  several  minor 
components of the  membrane  fraction  (17).  The  185,000- 
mol-wt protein is thought to be the PDGF receptor, whereas 
the  identity  of the  130,000-mol-wt  protein  is  not  known 
(although this is the molecular weight of vinculin as deter- 
mined by gel electrophoresis). Part of this phosphorylation is 
on the tyrosine residues in these proteins (10,  17, 26, 27, 48). 
In vivo, PDGF addition to Swiss 3T3 cells has been shown to 
phosphorylate two 45-kD, two 43-kD, and one 42-kD proteins 
at tyrosine residues (10). Similar changes were noted in these 
cells when they were exposed  to EGF,  which  suggests that 
phosphorylation of cellular substrates at tyrosine residues may 
be a common mechanism of action of the two growth factors. 
The lack of detectability of higher molecular weight phospho- 
rylated proteins (as was found in isolated membrane fractions) 
may be due to the biochemical fractionation procedures which 
involve the use of fluoride and EDTA, which stimulate phos- 
pho-tyrosine  protein  phosphatase  in  whole  cells  and  may 
rapidly dephosphorylate certain proteins (16). 
The  fact  that  the  PDGF  and  EGF  receptors  contain  a 
tyrosine kinase activity (8)  which is  similar to the tyrosine 
kinase  activity  of oncogene  protein  products  (23,  26,  52) 
suggests that the action of the receptor and oncogene proteins 
may be similar with respect to growth-promoting activity. It 
has recently been found that the src oncogene protein product 
has  been  localized  to  adhesion  plaques  (43,  50),  and  the 
alterations in actin distribution observed after oncogene trans- 
formation (11) are very similar to the early changes in actin 
distribution we observe after exposure of BALB/c-3T3  cells. 
Additional  work demonstrates that  the  tyrosine  kinase  src 
oncogene protein phosphorylates vinculin (28, 48). The recent 
findings which demonstrate that  vinculin  is a  substrate for 
protein kinase c (55), that phorbol esters have been shown to 
cause vinculin phosphorylation (54) and the specific redistri- 
bution of vinculin and actin (47),  and that PDGF addition 
results in  rapid  increases in  intracellular Ca 2+  (34),  suggest 
that phosphorylation of vinculin may regulate its activity with 
respect to cell growth. The very recent findings that the simian 
sarcoma virus oncogene (v-sis) codes for the ~ chain of PDGF 
(12,  14,  15,  29)  suggests  that  studies  of the  biochemical 
regulation of growth by PDGF may be important in helping 
elucidate the mechanisms of oncogenesis. 
Received for publication 28 September 1984, and in revised form 11 
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